November 2008
Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30            

July 29, 2005

Does a multi- vitamin a day keep osteoporosis away?

Citation:Adams J, Pepping J.; Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. Am J Health Syst Pharm. 2005 Aug 1;62(15):1574-81 Findings: Vitamin K is essential for the activation of vitamin K-dependent proteins, which are involved not only in blood coagulation but in bone metabolism and the inhibition of arterial calcification. Vitamin K deficiency causes reductions in bone mineral density and increases the risk of fractures. Concurrent use of menaquinone and vitamin D may substantially reduce bone loss. ************************************* Citation: Morris MS, Jacques PF, Selhub J.Relation between homocysteine and B-vitamin status indicators and bone mineral density in more >>

Posted by VJ@stanford at 09:39 AM | Comments (0)

July 28, 2005

Stanford Pain & Palliative Care Conference

Stanford Pain & Palliative Care Conference Venue: Fairchild Auditorium, Stanford Dates: September 23- 24, 2005 Conference highlights: Meets California AB 487 Criteria for 12CEU Pain & Palliative Care (State mandate for most physicians) Latest updates about legal issues in pain and physician assisted suicide Parallel pain and palliative care tracks Concurrent interactive breakout sessions for skill practice *************************** To register, contact: Megan Zimmerman Phone: (650) 498 7937 Email: meganz@stanford.edu Conference agenda and other details are attached. VJ Periyakoil, MD more >>

Continue reading "Stanford Pain & Palliative Care Conference"

Posted by VJ@stanford at 11:40 AM | Comments (0)

Stanford Geriatric Education Center

Looking for resources on cross cultural aging? Go to http://sgec.stanford.edu more >>

Posted by VJ@stanford at 11:18 AM | Comments (0)

NSAIDS and risk of MI

Citation: Hippisley-Cox J and Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: Population based nested case-control analysis. BMJ 2005 Jun 11; 330:1366-9. Outline: In this case control study in UK, a large database ( more than 7 million patients) from a general practice was used to identify 9218 cases with first myocardial infarctions and 86,349 controls ( matched for age and sex). Increased risk for MI was seen when any of these drugs were used within 3 months of MI or control index date. Diclofenac (adjusted odds ratio : 1.55) rofecoxib (adjusted more >>

Posted by VJ@stanford at 10:50 AM | Comments (0)

July 04, 2005

Forum on Geriatrics

Welcome to the private Forum on Geriatrics. Through this forum, we hope to foster communication among providers caring for aging and dying patients. You must have a SUNet ID and be a member to view this forum. For more information, please contact VJ Periyakoil - vsperiyakoil@hotmail.com more >>

Posted by ktboyd at 03:34 PM | Comments (0)

May 09, 2005

Dr James Hawkins on "Off-label drug use"

LETTERS TO THE EDITOR; SAN FRANCISCO CHRONICLE Sunday, May 8, 2005 'Off-label' drug use Editor -- Regarding your article, "A patient's right to know" (May 1): It is of vital importance that physicians discuss the use of all medications with patients and, if necessary, their relatives. However, the off-label use of medications, questioned in the article, must be allowed to continue. In this nation, there are growing numbers of elderly patients with various demential illnesses. It is very common for such patients to develop psychosis with delusions or hallucinations, depression, anxiety and/or behavior problems (striking out, kicking, biting, etc.) as more >>

Posted by VJ@stanford at 11:08 PM | Comments (0)

 
© 2009  Stanford University School of Medicine | Terms of Use Powered by IRT